Revive Therapeutics

Revive Therapeutics is a life sciences company focused on the research and development of treatments for rare diseases and infectious diseases. Revive's cannabinoid drug portfolio focuses on rare inflammatory diseases and has received FDA orphan drug designation for the use of CBD in treating autoimmune hepatitis (liver disease) and ischemia and reperfusion injury caused by organ transplantation.